Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
Medtronic
Colorcon
Johnson and Johnson

Last Updated: March 26, 2023

Glenmark Generics Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-seven approved drugs.

There are two tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:58
Ingredients:53
NDAs:67

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics ASHLYNA ethinyl estradiol; levonorgestrel TABLET;ORAL 203163-001 Feb 23, 2015 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Generics CICLOPIROX ciclopirox GEL;TOPICAL 091595-001 Feb 29, 2012 AB RX No Yes See Plans and Pricing See Plans and Pricing
Glenmark Generics RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 201967-001 Dec 31, 2012 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Generics ESZOPICLONE eszopiclone TABLET;ORAL 091166-001 Apr 15, 2014 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Generics PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077987-001 May 11, 2007 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Generics ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090135-002 Feb 25, 2010 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Boehringer Ingelheim
McKinsey
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.